Sun Pharma Launches New Ad Campaign to Raise Awareness of Acne and its Impact on Everyday Life

“Take on Acne” ad campaign emphasizes the discomfort and disruption caused by acne, especially among teens and young adults. 

PRINCETON, N.J.--()--Sun Dermatology, a division of Sun Pharmaceutical Industries, Inc., USA, which is a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (together “Sun Pharma”), today announced the launch of Take on Acne – a new advertising campaign designed to raise awareness of the profound impact of acne on everyday life, particularly among teenagers and young adults (roughly 12-25 years of age). A common condition, acne affects more than 85% of adolescents and, depending on its severity, persistence and other factors, is highly correlated with psychosocial problems and low self-esteem.1

The Take on Acne ads depict the disruptive nature of powerful and painful acne breakouts that often seem to come out of nowhere. Featuring strong, empowering messages such as, “You are not your acne” and “Take back your face,” the campaign emphasizes the biological and genetic causes of acne, while dispelling misperceptions that the condition is always caused by poor hygiene or diet.

Take on Acne is meant to empower people with acne to re-gain control as their lives are interrupted by breakouts that can feel uncontrolled and overwhelming,” said Andy Nelson, Vice President, Sales and Marketing, Medical Dermatology, Sun Pharma. “By showing what adolescents with acne are going through, our aim is to give rise to the voice of the patient in a meaningful way, underscoring our commitment to these patients and the dermatology professionals who serve them.”

The ad concept is the result of research Sun Pharma conducted to understand how acne impacts teens and young adults, and how they experience this condition in their own words. The research uncovered common themes through personal expressions of psychosocial angst, hopelessness, and isolation.2 Research participants reported viewing themselves through a distorted lens, as if defined by their condition, and admitted to self-retreating to avoid being judged.

“Adolescence is a highly vulnerable life-stage for anyone, and the vulnerability is often magnified for those suffering from the more severe forms of acne,” said Nicholas Squittieri, MD, chief medical officer of Sun Pharma. “Take on Acne intentionally uses provocative imagery to urge people with acne to seek earlier intervention, which can not only prevent formation of physical scars, but also lifelong psychosocial scars. It’s also important that people know that some forms of acne are medical conditions that require clinical intervention.”

The Take on Acne campaign will run in a variety of online digital, video, audio, gaming, and social media outlets, as well as on digital billboards across the U.S. Individuals seeking more information can visit to assess if and when to take action and to opt-in to receive acne-related materials.

About Sun Dermatology

Sun Dermatology (the branded dermatology division of a wholly owned subsidiary of Sun Pharmaceutical Industries, Inc.) is committed to expanding its dermatology portfolio to bring healthcare providers and patients around the world more treatment options and ongoing support for conditions like moderate-to-severe plaque psoriasis, severe nodular acne, and actinic keratosis. Sun Pharmaceutical Industries Ltd., along with its subsidiaries, is ranked fourth in dermatology prescription volume within the U.S. per IQVIA and is the fourth largest specialty generic pharmaceutical company globally.



  1. Ayer J, Burrows N. Acne: more than skin deep. Postgraduate Medical Journal. 2006;82:500-506.
  2. Geiler, U., Geiler, T, Kupfer, JP. Acne and quality of life – impact and management. Journal of the European Academy of Dermatology and Venerology. 2015;29(Suppl 4):12-14.



Vinita Alexander
Tel Direct +609-720-8197

Reba Auslander
Tel Direct +917-836-9308


Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Sun Pharmaceutical Industries Ltd.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in over 100 countries across the world, at affordable prices. Its global presence is supported by manufacturing facilities spread across 6 continents and approved by multiple regulatory agencies, coupled with a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities across multiple R&D centers, with investments of approximately 7% of annual revenues in R&D.